Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-30

FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA approves a supplemental application for TASMAR (tolcapone) filed by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tasmar (tolcapone)

Snippet

SUPPL AP for TASMAR (TOLCAPONE)